Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Common Shares, $0.01 par value
-
Shares outstanding
-
29,596,439
-
Total 13F shares
-
4,901,740
-
Share change
-
+195,091
-
Total reported value
-
$96,913,930
-
Price per share
-
$19.75
-
Number of holders
-
61
-
Value change
-
+$4,277,096
-
Number of buys
-
36
-
Number of sells
-
21
Institutional Holders of abrdn Life Sciences Investors - Common Shares, $0.01 par value (HQL) as of Q4 2020
As of 31 Dec 2020,
abrdn Life Sciences Investors - Common Shares, $0.01 par value (HQL) was held by
61 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,901,740 shares.
The largest 10 holders included
NEEDHAM INVESTMENT MANAGEMENT LLC, 1832 Asset Management L.P., WELLS FARGO & COMPANY/MN, MORGAN STANLEY, Advisors Asset Management, Inc., Matisse Capital, FLAGSHIP HARBOR ADVISORS, LLC, COHEN & STEERS, INC., LAZARD ASSET MANAGEMENT LLC, and 1607 Capital Partners, LLC.
This page lists
61
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.